Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
1.105
-0.015 (-1.34%)
Dec 3, 2024, 12:19 PM EST - Market open
Adicet Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Cash & Equivalents | 105.48 | 159.71 | 257.66 | 277.54 | 84.33 | 10.61 | Upgrade
|
Short-Term Investments | 96.58 | - | - | - | 10.28 | 51.79 | Upgrade
|
Cash & Short-Term Investments | 202.07 | 159.71 | 257.66 | 277.54 | 94.61 | 62.4 | Upgrade
|
Cash Growth | 10.26% | -38.01% | -7.17% | 193.34% | 51.63% | 153.21% | Upgrade
|
Accounts Receivable | - | - | - | 0.19 | - | - | Upgrade
|
Other Receivables | 0.21 | - | 0.44 | 0.03 | 2.73 | 0.94 | Upgrade
|
Receivables | 0.21 | - | 0.44 | 0.21 | 2.73 | 0.94 | Upgrade
|
Prepaid Expenses | 4.04 | 2.56 | 2.95 | 4.68 | 2.76 | 0.67 | Upgrade
|
Other Current Assets | - | - | - | - | 0.23 | 0.18 | Upgrade
|
Total Current Assets | 206.32 | 162.27 | 261.04 | 282.44 | 100.34 | 64.19 | Upgrade
|
Property, Plant & Equipment | 39.14 | 44.2 | 48.98 | 35 | 25.86 | 2.12 | Upgrade
|
Long-Term Investments | - | - | - | - | - | 10.59 | Upgrade
|
Goodwill | - | - | 19.46 | 19.46 | 20.09 | - | Upgrade
|
Other Intangible Assets | - | - | - | - | 1.19 | - | Upgrade
|
Other Long-Term Assets | 0.51 | 0.82 | 1.21 | 2.04 | 6.36 | 4.69 | Upgrade
|
Total Assets | 245.96 | 207.3 | 330.69 | 338.94 | 153.84 | 81.59 | Upgrade
|
Accounts Payable | 2.5 | 2.63 | 4.4 | 3.26 | 1.55 | 1.05 | Upgrade
|
Accrued Expenses | 13.62 | 13.44 | 12.81 | 6.68 | 5.73 | 2.82 | Upgrade
|
Current Portion of Leases | 3.28 | 3.22 | 2.49 | 1.57 | 1.22 | - | Upgrade
|
Current Unearned Revenue | - | - | - | 4.81 | 13.98 | 10.99 | Upgrade
|
Total Current Liabilities | 19.39 | 19.29 | 19.71 | 16.32 | 22.48 | 14.87 | Upgrade
|
Long-Term Leases | 14.92 | 17.7 | 18.53 | 19.38 | 20.42 | - | Upgrade
|
Long-Term Unearned Revenue | - | - | - | - | - | 10.89 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.13 | - | Upgrade
|
Other Long-Term Liabilities | 0.12 | 0.13 | 0.11 | 0.12 | 0.98 | 0.23 | Upgrade
|
Total Liabilities | 34.43 | 37.12 | 38.35 | 35.81 | 44.01 | 25.99 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | - | Upgrade
|
Additional Paid-In Capital | 680.57 | 550.94 | 530.45 | 471.45 | 216.13 | 9.26 | Upgrade
|
Retained Earnings | -469.17 | -380.77 | -238.11 | -168.32 | -106.33 | -69.65 | Upgrade
|
Comprehensive Income & Other | 0.12 | - | - | - | 0.02 | 0.02 | Upgrade
|
Total Common Equity | 211.53 | 170.18 | 292.34 | 303.13 | 109.83 | -60.37 | Upgrade
|
Shareholders' Equity | 211.53 | 170.18 | 292.34 | 303.13 | 109.83 | 55.6 | Upgrade
|
Total Liabilities & Equity | 245.96 | 207.3 | 330.69 | 338.94 | 153.84 | 81.59 | Upgrade
|
Total Debt | 18.2 | 20.92 | 21.02 | 20.94 | 21.64 | - | Upgrade
|
Net Cash (Debt) | 183.87 | 138.79 | 236.63 | 256.6 | 72.98 | 72.99 | Upgrade
|
Net Cash Growth | 13.88% | -41.35% | -7.78% | 251.63% | -0.02% | 238.99% | Upgrade
|
Net Cash Per Share | 2.42 | 3.22 | 5.76 | 8.29 | 9.97 | 34.12 | Upgrade
|
Filing Date Shares Outstanding | 82.4 | 82.15 | 42.95 | 39.88 | 31.78 | 17.38 | Upgrade
|
Total Common Shares Outstanding | 82.4 | 43.27 | 42.95 | 39.74 | 19.68 | 17.38 | Upgrade
|
Working Capital | 186.92 | 142.99 | 241.33 | 266.12 | 77.86 | 49.32 | Upgrade
|
Book Value Per Share | 2.57 | 3.93 | 6.81 | 7.63 | 5.58 | -3.47 | Upgrade
|
Tangible Book Value | 211.53 | 170.18 | 272.88 | 283.67 | 88.55 | -60.37 | Upgrade
|
Tangible Book Value Per Share | 2.57 | 3.93 | 6.35 | 7.14 | 4.50 | -3.47 | Upgrade
|
Machinery | 14.84 | 14.31 | 7.86 | 6.02 | 4.97 | 3.98 | Upgrade
|
Construction In Progress | 1.87 | 0.27 | 9.29 | 13.01 | 1.09 | 0.3 | Upgrade
|
Leasehold Improvements | 26.66 | 26.64 | 19.96 | 1.61 | 1.43 | 1.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.